M&A Deal Summary |
|
|---|---|
| Date | 2025-12-11 |
| Target | Applied Therapeutics |
| Sector | Life Science |
| Buyer(s) | Cycle Pharmaceuticals |
| Deal Type | Add-on Acquisition |
SEARCH BY
Cycle Pharmaceuticals is a developer of rare disease therapies focuses on rare metabolic, immunological, and neurological genetic conditions. Cycle Pharmaceuticals was founded in 2012 and is based in Cambridge, United Kingdom.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Life Science M&A | 2 of 2 |
| Type: Add-on Acquisition M&A Deals | 2 of 2 |
| State: New York M&A | 1 of 1 |
| Country: United States M&A | 2 of 2 |
| Year: 2025 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-10-14 |
Vanda Pharmaceuticals
Washington, District of Columbia, United States Vanda Pharmaceuticals is a bio pharmaceutical company focused on the development and commercialization of innovative therapies. Vanda Pharmaceuticals is based in Washington, District of Columbia. |
Buy | - |